Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUEEN-IVF trial of quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation
NL-OMON60033Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of quinidine and verapamil in idiopathic ventricular fibrillation (IVF) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Sustained ventricular arrhythmia severity score. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
quinidineverapamil
03
Conditions
idiopathic ventricular fibrillation (IVF)
Beyond the preview
Go deeper on NL-OMON60033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60033.